Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dan Tao
Observed institutions:
China National Pharmaceutical Group Corporation (China),
Baotou Medical College
ORCID:
0000-0002-6593-0183
Observed ORCID:
0000-0002-6593-0183
OpenAlex ID:
A5065447808
The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury
2022
·
Wenlu Ma
, Xiaomei Miao
, et al.
·
Computational and Mathematical Methods in Medicine
·
14
PDF
Pancytopenia Due to Possible Drug–Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors
2022
·
Dan Tao
, Hui Wang
, et al.
·
Drug Healthcare and Patient Safety
·
12
PDF
Oral Semaglutide and the Kidney: Promise, Limitations, and the Road Ahead
2026
·
Wenlu Ma
, Fangfang Xia
, et al.
·
Diabetes Care
PDF
Show more works
View as search
Works count:
3
Citation count:
26
H-index:
2
I10-index:
2
Year
Topic
Type